BS

Binney Street Capital

North America, Massachusetts, United States, Boston

Description

Binney Street Capital is a venture fund associated with the Dana-Farber Cancer Institute in Boston.

Investor Profile

Binney Street Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series A (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Biopharma
  • Therapeutics
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Binney Street Capital frequently co-invest with?

Alexandria
North America, California, United States, San Francisco
Co-Investments: 1
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Sixty Degree Capital
North America, Ontario, Canada, Toronto
Co-Investments: 2
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 3
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
AbbVie
North America, Illinois, United States, North Chicago
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 2

Which angels does Binney Street Capital often collaborate with?

GF
North America, California, United States
Shared Deals: 2

What are some of recent deals done by Binney Street Capital?

Predicta Biosciences

Boston, Massachusetts, United States

Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsLife ScienceTherapeutics
Series AOct 1, 2025
Amount Raised: $23,400,000
NextPoint Therapeutics

Cambridge, Massachusetts, United States

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BFeb 14, 2024
Amount Raised: $42,500,000
Precede Biosciences

Boston, Massachusetts, United States

Precede Biosciences is breaking down the barriers to precision medicine by redefining what can be gleaned from a simple blood draw.

BiopharmaBiotechnologyHealth Care
Series AOct 5, 2023
Amount Raised: $57,000,000
NextPoint Therapeutics

Cambridge, Massachusetts, United States

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BJan 10, 2023
Amount Raised: $80,000,000
Kojin Therapeutics

Cambridge, Massachusetts, United States

Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.

BiopharmaBiotechnologyHealth CareLife ScienceMedical
Series AJun 9, 2021
Amount Raised: $60,000,000